Azzariti, Amalia
De Summa, Simona
Marvulli, Tommaso M.
De Risi, Ivana
De Palma, Giuseppe
Di Fonte, Roberta
Fasano, Rossella
Serratì, Simona
Strippoli, Sabino
Porcelli, Letizia
Guida, Michele
Funding for this research was provided by:
Regione Puglia (Tecnopolo per la Medicina di Precisione)
Ministero della Salute (RC 2022-2024: Identificazione di fattori circolanti per la diagnosi, prognosi e/o predizione della risposta alle terapie in patologie tumorali solide)
Article History
Received: 4 October 2024
Accepted: 28 January 2025
First Online: 5 February 2025
Declarations
:
: The study was previously approved by the ethics committee of the IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy, (Prot. 590/16 C.E.) and written informed consent was obtained from all the patients enrolled in the study.
: Not applicable.
: The authors affiliated to the IRCCS Istituto Tumori Giovanni Paolo II are responsible for the views expressed in this article, which do not necessarily represent the ones of the Institute.
: The authors declare that they have no competing interests.